|
|
 |
|
Total Number of Holdings (excluding cash): 51
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
150 |
$44,638.50 |
2.40% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
10,500 |
$41,901.32 |
2.26% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$41,332.50 |
2.22% |
| Teleflex Incorporated |
TFX |
879369106 |
326 |
$40,394.66 |
2.17% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,285 |
$40,142.68 |
2.16% |
| Baxter International Inc. |
BAX |
071813109 |
2,250 |
$39,555.00 |
2.13% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,268 |
$39,489.55 |
2.13% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,240 |
$39,324.85 |
2.12% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
86 |
$39,354.46 |
2.12% |
| Align Technology, Inc. |
ALGN |
016255101 |
223 |
$39,250.23 |
2.11% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
361 |
$39,178.88 |
2.11% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,434 |
$39,154.15 |
2.11% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,940 |
$38,751.93 |
2.09% |
| Agilent Technologies, Inc. |
A |
00846U101 |
335 |
$38,709.25 |
2.08% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
138 |
$38,656.56 |
2.08% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
427 |
$38,506.86 |
2.07% |
| Masimo Corporation |
MASI |
574795100 |
216 |
$38,540.88 |
2.07% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
565 |
$38,521.70 |
2.07% |
| Penumbra, Inc. |
PEN |
70975L107 |
117 |
$38,198.16 |
2.06% |
| Steris Plc |
STE |
G8473T100 |
173 |
$37,520.24 |
2.02% |
| Becton, Dickinson and Company |
BDX |
075887109 |
250 |
$37,260.00 |
2.01% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
78 |
$37,358.88 |
2.01% |
| Waters Corporation |
WAT |
941848103 |
121 |
$37,416.83 |
2.01% |
| Revvity, Inc. |
RVTY |
714046109 |
430 |
$37,246.60 |
2.00% |
| Alcon Inc. |
ALC.SW |
H01301128 |
494 |
$36,878.25 |
1.99% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
337 |
$36,985.75 |
1.99% |
| LivaNova Plc |
LIVN |
G5509L101 |
615 |
$36,961.50 |
1.99% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
29 |
$37,021.69 |
1.99% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,711 |
$36,872.58 |
1.98% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
167 |
$36,607.76 |
1.97% |
| Danaher Corporation |
DHR |
235851102 |
203 |
$36,326.85 |
1.96% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,860 |
$36,390.69 |
1.96% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$36,228.30 |
1.95% |
| ResMed Inc. |
RMD |
761152107 |
169 |
$36,133.89 |
1.95% |
| Boston Scientific Corporation |
BSX |
101137107 |
624 |
$35,948.64 |
1.94% |
| DexCom, Inc. |
DXCM |
252131107 |
603 |
$35,908.65 |
1.93% |
| Medtronic Plc |
MDT |
G5960L103 |
442 |
$35,788.74 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$35,924.82 |
1.93% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,355 |
$35,742.04 |
1.92% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
193 |
$35,668.78 |
1.92% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
871 |
$35,714.77 |
1.92% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
574 |
$35,458.09 |
1.91% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,299 |
$35,574.25 |
1.91% |
| Abbott Laboratories |
ABT |
002824100 |
385 |
$34,954.15 |
1.88% |
| The Cooper Companies, Inc. |
COO |
216648501 |
542 |
$34,091.80 |
1.84% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
414 |
$34,126.02 |
1.84% |
| Insulet Corporation |
PODD |
45784P101 |
196 |
$33,739.44 |
1.82% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
527 |
$32,062.68 |
1.73% |
| BioMerieux |
BIM.FP |
F1149Y232 |
365 |
$30,800.65 |
1.66% |
| Cochlear Limited |
COH.AU |
Q25953102 |
317 |
$21,569.01 |
1.16% |
| US Dollar |
$USD |
|
7,572 |
$7,571.75 |
0.41% |
| Japanese Yen |
$JPY |
|
44,982 |
$287.24 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|